Friedlander, M. (2009). Combination angiostatic therapies: targeting multiple angiogenic pathways. Retina. 2009 Jun;29(6 Suppl):S27-9.
Aguilar E, Dorrell MI, Friedlander D, Jacobson RA, Johnson A, Marchetti V, Moreno SK, Ritter MR, and M. Friedlander (2008). Ocular models of angiogenesis. Methods in Enzymology 444:115-58.
Dorrell, M., Usitalo-Jarvinen, H., Aguilar, E.A. and Friedlander, M. (2007). Ocular angiogenesis; basic mechanisms and therapeutic advances. Survey of Ophthalmology 52 (Supplement 1):S3-S19.
Friedlander, M. (2007). Fibrosis and diseases of the eye. J. Clin. Invest. 117: 117:576-586.
Friedlander, M., Dorrell, M.I., Ritter, M.R., Marchetti, V., Moreno, S.K., El-Kalay, M., Bird, A.C., Banin, E., Aguilar, E., (2007). Progenitor cells and retinal angiogenesis. Angiogenesis, 10:89-101.
Dorrell, M.I. and M. Friedlander (2007). Retinal Vascular and RPE Gene Expression. In The Mouse Visual System Handbook (L.M. Chalupa, ed.). MIT Press.
Ritter, M.R., R. Butschek, S.F. Friedlander and M. Friedlander (2007). Pathogenesis of infantile hemangioma: new molecular and cellular insights. Expert Rev. in Mol. Med., 9:1-19.
Dorrell, M.I., M. Friedlander, Smith, L.E.H. (2007). Retinal vascular development in Retinal Vascular Disease (A.M. Joussen, T.W. Gardner, B. Kirchhof and S.J. Ryan, eds). Springer, Berlin. pp 24-37.
Dorrell, M.I. and Friedlander, M. (2006). Cell guidance in retinal angiogenesis. Progress in Retinal and Eye Research. 25(3):277-95.
Ritter, M. and Friedlander, M. (2006). Integrins in Ocular Angiogenesis. In Ocular Angiogenesis (J. Tobran-Tink and C. Barnstable, eds.), pp 279-290. Humana Press;Totowa, NJ.
Friedlander, M. (2005). Stem cells and retinal disease. In The Retina 4th Edition, (S. Ryan, ed.), pp 23-32. Elsevier Publishers.
Otani, A. and Friedlander, M. (2005). Retinal vascular regeneration. Seminars in Ophthalmology 20:43-50.
Friedlander, S.F., Ritter, M., and Friedlander, M. (2005). Recent progress in our understanding of the pathogenesis of infantile hemangioma. Lymph. Res. and Biol. 3:219-225.
Lutty, G.A., Chan-Ling, T., Phelps, D.L., Adamis, A.P., Berns, K.I., Chan, C.K., Cole, C.H., D'Amore, P.A., Das, A., Deng, W.T., Dobson,V., Flynn, J.T., Friedlander, M., Fulton, A., Good, W.V., Grant, M.B., Hansen, R., Hauswirth, W.W., Hardy, R.J., Hinton, D.R., Hughes, S., McLeod, D.S., Palmer, E.A., Patz, A., Penn, J.S., Raisler, B.J., Repka, M.X., Saint-Geniez, M., Shaw, L.C., Shima, D.T., Smith, B.T., Smith, L. E., Tahija, S. G., Tasman, W., Trese, M.T. (2006). Proceedings of the Third International Symposium on Retinopathy of Prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California), Molecular Vision 12:532-580.
Dr. Friedlander's research interests focus on understanding basic underlying mechanisms of ocular angiogenesis and identifying therapeutic approaches to treating ocular neovascular diseases such as macular degeneration and diabetic retinopathy.
The Friedlander Laboratory
10550 North Torrey Pines Road
La Jolla, CA 92037
(858) 784-2958 Michele Gerhart
Laboratory Administrative Assistant
(858) 784-2930 Telephone
(858) 784-2504 Fax